Stocks-02196.HK-Shanghai Fosun Pharmaceutical

02196.HK Shanghai Fosun Pharmaceutical

0 0 (0%)
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Shanghai Fosun Pharmaceutical's revenues increased by 8.79% and amounted to 50.95B. Net income decreased by 23.51% to 4.60B. Net assets increased by 2.68% to 60.69B and EPS decreased from 2.23 to 1.67.
02196.HK's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
49.17%
Net Profit Margin
11.14%
Operating Margin
5.75%
Return On Investment
7.83%